Press Releases
NowVertical Announces Release of Units from Escrow to Teraz Fund
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (the “Company” or “NowVertical”) is pleased to announce that, further to its news release dated October 20, 2026, the TSX Venture Exchange (the “TSXV”) has cleared the Personal Information Forms required in connection with the subscription by Teraz Fund (“Teraz”) for Units (as defined below) in the first tranche (the “First Tranche”) of the Company's private placement offering for gross proceeds of $15,100,000 (the “Offering”). Accordingly, the 15,833,334 Units subscribed for by Teraz that closed in escrow (the “Escrowed Units”), together with the related subscription proceeds of $1,900,000, have been released from escrow...
MARA Schedules Conference Call for Third Quarter 2026 Financial Results
Earnings Webcast and Conference Call Set for Monday, November 9, 2026 at 5:00 p.m. Eastern Time
Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach
AUSTIN, Texas, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management software and payroll tax management solutions, and Vertex, Inc. (NASDAQ:VERX), the Decision-to-Defense™ global indirect tax and compliance company, today announced a strategic partnership designed to deliver an improved payroll tax calculation and compliance offering to the U.S. enterprise market. The partnership includes Vertex's payroll tax calculation technology with Asure's Payroll Tax Management infrastructure for tax filing, remittance, W-2 processing, agency notice management and interaction with thousands of federal, state and local taxing authorities...
Edible Garden CEO Jim Kras to Discuss Innovation and Diversification at 2026 CEAg World Conference & Expo
Jim Kras will discuss Diversification Beyond Core CEA at CEAg World Conference & Expo BELVIDERE, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired mission and Farm-to-Formula platform, today announced that Chief Executive Officer Jim Kras will participate in the 2026 CEAg World Conference & Expo, taking place November 10–11, 2026, in Charlotte-Concord, North Carolina. Mr. Kras will participate in a session titled “Diversification Beyond Core CEA” on Tuesday, November 10, 2026...
Fluence Strengthens Executive Leadership Team to Accelerate Operational Transformation
Siemens and AES veteran executives Axel Meier and Ricardo Roizen appointed Interim CEO and Interim CFO; global operations and transformation executive Marco Boos named Senior Vice President & Chief Customer Success Officer Board of Directors establishes Manufacturing and Operations Oversight Committee to provide focused oversight of transformation ARLINGTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence” or the “Company”) (NASDAQ: FLNC) today announced a series of executive leadership changes that mark an important step in the Company's ongoing operational transformation...
ICBA Adds Jack Henry's Treasury Management Solution to Preferred Service Provider Program
Platform helps community banks compete for larger commercial relationships, grow deposits, and generate fee income JHA Treasury Management helps community banks serve more complex business customers The solution offers greater financial control and visibility, more flexibility and added security The Preferred Service Provider program makes the product available to all ICBA members MONETT, Mo., Nov. 2, 2026 /PRNewswire/ -- Jack Henry (Nasdaq: JKHY) announced today that JHA Treasury Management™ has been added to the Independent Community Bankers of America (ICBA) Preferred Service Provider (PSP) program...
Axcelis Technologies and Veeco Instruments Provide Update on Expected Timing of Merger Closing
Merger now expected to close by the end of the first quarter of 2027 BEVERLY, Mass., and PLAINVIEW, N.Y.
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
BOULDER, Colo., Nov. 2, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading clinical-stage cardiovascular biopharmaceutical company, today announced that on October 30, 2026, Edgewise granted inducement stock options to purchase a total of 17,250 shares of Edgewise's common stock and awards of inducement restricted stock units (each, an "RSU award") covering a total of 8,626 shares of Edgewise's common stock to 2 new non-executive employees in connection with the commencement of their employment, pursuant to Edgewise's 2024 Inducement Equity Incentive Plan (the "Inducement Plan")...
PTC Therapeutics to Participate in Upcoming Investor Conferences
WARREN, N.J., Nov. 2, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Jefferies Global Healthcare Conference Monday, Nov. 16 at 11 a.m.
Hemisphere Energy Provides Insurance Claim and Operations Updates
Vancouver, British Columbia--(Newsfile Corp. - November 2, 2026) - Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) ("Hemisphere" or the "Company") is pleased to provide an update on its insurance claim related to the previously reported fire at its Atlee G pool battery and the restoration of operations at Atlee Buffalo. Hemisphere has begun to receive funds from its insurance providers for an approved $15 million lump-sum interim payment toward its property damage and business interruption insurance claim in relation to the previously announced fire at its Atlee G pool battery...
ASML reports transactions under its current share buyback program
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.
Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences
WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis (CF), today announced that management will participate in fireside chats at the following upcoming investor events:
Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets
Oral tablet form expected to allow Company to optimize patient plasma exposure levels with convenient daily dosing of drug
Radiopharm Theranostics Reports Business Update
Phase 3 imaging trial of RAD101 in recurrent brain metastases from solid tumors expected to initiate in 1Q27 following successful end-of-phase 2 meeting with U.S. Food and Drug Administration
UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
Phase 1 clinical trial to evaluate local intravesical administration of UGN-501 UGN-501 is a differentiated investigational next-generation oncolytic virus designed to combine direct tumor cell destruction with anti-tumor immune activation PRINCETON, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd...
STMicroelectronics announces status of common share repurchase program
STMicroelectronics announces status of common share repurchase program Disclosure of Transactions in Own Shares – Period from October 26, 2026 to October 30, 2026 AMSTERDAM – November 2, 2026 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated June 21, 2024...
CVW Sustainable Royalties Announces CFO Transition and Grant of Equity Awards
Calgary, Alberta--(Newsfile Corp. - November 2, 2026) - CVW Sustainable Royalties Inc. (TSXV: CVW) (OTCQX: CVWFF) (FSE: TMD) ("CVW Royalties" or the "Company") today announces the appointment of Joel Kuntz, CPA, CA as Chief Financial Officer and Corporate Secretary, effective November 2, 2026. Mr. Kuntz succeeds Joshua Grant, who will assist with the transition following Mr...
Actinium Pharmaceuticals Announces Acceptance of ATNM-400 Abstract for Presentation at SABCS 2026 Highlighting Activity Across Therapy-Resistant Breast Cancer Models
Poster presentation to highlight preclinical efficacy of ATNM-400 across therapy-resistant breast cancer subtypes ATNM-400 is a first-in-class targeted alpha therapy directed against HER3, a driver of tumor biology and treatment resistance in multiple solid tumors Breast cancer findings reinforce ATNM-400's pan-tumor potential, building on previously reported preclinical results in non-small cell lung, colorectal and ovarian cancers NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today announced that an abstract highlighting preclinical efficacy of ATNM-400 across therapy-resistant breast cancer subtypes has been accepted for poster presentation at the 2026 San Antonio Breast Cancer Symposium (SABCS), taking place December 8–11, 2026, in San Antonio, Texas. The presentation will feature ATNM-400, the Company's investigational, first-in-class Actinium-225 (²²⁵Ac) antibody radioconjugate targeting HER3, an antigen implicated in tumor survival and treatment resistance...
Honeywell Aerospace announces participation at upcoming investor conferences
PHOENIX, Nov. 2, 2026 /PRNewswire/ -- Honeywell Aerospace (Nasdaq: HONA) today announced its participation at upcoming investor conferences in the fourth quarter. On Tuesday, November 10, 2026, Jim Currier, Chief Executive Officer of Honeywell Aerospace, will present at the Baird Global Industrial Conference in Chicago, Illinois at 7:55 a.m...
Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026
DURHAM, N.C, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company will release its financial results for the three months and nine months ended September 30, 2026, on Tuesday, November 10, 2026. Management will host a webcast and conference call at 8:00 a.m. Eastern Time to provide a corporate and financial update...
TOYO to Exhibit at RE+ 2026 and Participate in ROTH Solar & Storage Symposium
TOKYO, Nov. 2, 2026 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO; OTC: TOYWF) ("TOYO" or the "Company"), a solar manufacturing company, today announced that it will exhibit at RE+ 2026, taking place November 16–19, 2026, at the Las Vegas Convention Center in Las Vegas, Nevada. The Company will also participate in the 13th Annual ROTH Solar & Storage Symposium, held during RE+ on November 17, 2026...
Nuvation Bio to Present Additional Updated Phase 2 Results at 2026 Society for Neuro-Oncology Annual Meeting
Nuvation Bio will present four posters: one will showcase updated long-term Phase 2 results; three posters highlight trial in progress overviews for ongoing safusidenib studies Poster featuring Phase 2 results to be presented at SNO includes additional data beyond topline results previously announced in July 2026 NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that additional updated results from the Phase 2 J201 study and three posters on ongoing studies of safusidenib, its selective investigational inhibitor of mutant IDH1, will be presented at the Society for Neuro-Oncology (SNO) Annual Meeting taking place November 12–15, 2026, in Philadelphia, PA. Positive topline Phase 2 J201 results were announced in July; additional key data will be featured in the SNO poster...
Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
BRISBANE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that the Company's management team will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference, which is taking place in Boston, MA from November 9-11, 2026...
DICK'S Sporting Goods, Inc. Third Quarter Results Call Scheduled for November 24th
PITTSBURGH, Nov. 2, 2026 /PRNewswire/ -- DICK'S Sporting Goods, Inc. (NYSE: DKS) will announce results for the third quarter of fiscal 2026 before the market opens on Tuesday, November 24th. A conference call to discuss the results will be held that day at 8:00 a.m.
Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent
Industry experts challenged to distinguish specialized recruiters from AI-assisted generalists, demonstrating how advanced AI can bring domain expertise into everyday enterprise recruiting workflows Industry experts challenged to distinguish specialized recruiters from AI-assisted generalists, demonstrating how advanced AI can bring domain expertise into everyday enterprise recruiting workflows
Royal Purple Unveils New Three-Tier Performance Motor Oil Lineup at AAPEX 2026
High Performance, new Ultimate High Performance, and Extreme Performance Racing give drivers a clear path from daily driving to the track, with the lineup arriving at retail beginning January 2027. LAS VEGAS, Nov. 2, 2026 /PRNewswire/ -- Royal Purple, the synthetic lubricant brand recognized by its signature purple oil, tomorrow announces a reimagined passenger car motor oil lineup, which it will unveil when AAPEX 2026 opens Tuesday morning...
Save the Date: Nova to Host Investor Day on March 9, 2027
REHOVOT, Israel, Nov. 2, 2026 /PRNewswire/ -- Nova (Nasdaq: NVMI), a leading innovator and a key provider of advanced metrology and process control solutions used in semiconductor manufacturing, today announced that it will host an Investor Day on March 9, 2027, at the Nasdaq MarketSite in New York City. Those interested in attending the event in-person are invited to RSVP to the event through the link - https://www.novami.com/investor-day-2027/...
FIRST RESOURCE BANCORP, INC. ANNOUNCES QUARTERLY CASH DIVIDEND
EXTON, Pa., Nov. 2, 2026 /PRNewswire/ -- First Resource Bancorp, Inc. (OTCQX: FRSB) today announced that First Resource's Board of Directors declared a regular quarterly cash dividend of $0.02 per share on the Company's common stock. The dividend is payable on December 2, 2026 to shareholders of record as of November 18, 2026...
FOX REPORTS FIRST QUARTER FISCAL 2027 REVENUE OF $4.57 BILLION, NET INCOME OF $957 MILLION, AND ADJUSTED EBITDA OF $1.64 BILLION
NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Fox Corporation (Nasdaq: FOXA, FOX) ("FOX" or the "Company") today reported financial results for the three months ended September 30, 2026. The Company reported total quarterly revenue of $4.57 billion, an increase of $833 million or 22% as compared to the amount reported in the prior year quarter...
Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective
Special meeting of Chemomab shareholders to vote on the proposed merger scheduled for December 4, 2026 TEL AVIV, Israel, and DURHAM, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Chemomab Therapeutics (Nasdaq: CMMB) (“Chemomab”) and Scipher Medicine Corporation (“Scipher”), a leader in immunology precision medicine, today announced that on October 30, 2026, the U.S. Securities and Exchange Commission (“SEC”) declared effective the Registration Statement on Form S-4 (as amended, the “Registration Statement”) filed by Chemomab and Snowdrift Parent Corporation in connection with the previously announced proposed business combination between Chemomab and Scipher...
Autodesk extends invitation to join financial results conference call
Third quarter fiscal 2027 financial results conference call to be held Tuesday, November 24, 2026, 2 p.m. PT SAN FRANCISCO, Nov. 2, 2026 /PRNewswire/ -- Autodesk, Inc. (NASDAQ: ADSK) today announced it will share its third quarter fiscal 2027 financial results conference call via its website on Tuesday, November 24, 2026, at 2 p.m...
Innventure Announces Formation of Strategic Review Committee to Review Range of Capital Strategies
ORLANDO, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) ("Innventure" or the "Company"), today announced that its Board of Directors (the "Board") has formed a Strategic Review Committee (the “Committee”) of disinterested directors to oversee a wide range of strategic matters, including an evaluation of capital strategies and other strategic priorities to create shareholder value...
Magna to Host Investor Day on November 11, 2026
AURORA, Ontario, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Magna International Inc. (NYSE:MGA; TSX:MG) will host its 2026 Investor Day in New York City on Wednesday, November 11, beginning at 9 a.m. ET. The event will feature presentations by Swamy Kotagiri, President and Chief Executive Officer, Philip Fracassa, Executive Vice-President and Chief Financial Officer, and other members of the Magna leadership team...
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
– Theriva received a $350,000 upfront payment at closing and is eligible for up to $91 million in regulatory and sales milestones, along with low single-digit royalties on net product sales – – Biossil to assume all responsibility and costs for future development and commercialization of the antibiotic-degrading enzyme portfolio – ROCKVILLE, Md., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced the sale of the Company's portfolio of antibiotic-degrading enzymes — including SYN-004 (ribaxamase), SYN-007 (reformulated ribaxamase), and SYN-006 (carbapenemase) — to Biossil Labs Inc. (Biossil), a privately held, Toronto-based, artificial intelligence (AI)-native biopharmaceutical company advancing a diverse portfolio of late-stage programs in life-threatening indications with urgent unmet needs...
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
MONTREAL and CHARLOTTE, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced new data showing that CARDAMYST (etripamil) nasal spray converted approximately two-thirds of patients who experienced recurrent symptomatic paroxysmal supraventricular tachycardia (PSVT) after a prior catheter ablation to normal heart rhythm within 30 minutes...
XMax Announces AI Infrastructure Services Agreement, Expects Over US$100 Million in Revenue Over the Next Five Years
Advancing NeoCloud and AI Token Factory Commercialization Leveraging kt cloud's high-performance computing, targeting scale of 512 NVIDIA Blackwell Ultra B300 GPUs LOS ANGELES, Nov. 02, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ: XMAX) (“XMax” or the “Company”), a distributor of contemporary furniture and artificial intelligence software and platform-based service provider, today announced that it has entered into a five-year artificial intelligence (“AI”) infrastructure services agreement with DSH HYPER PTE. LTD. of Singapore (“DSH”)...
Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response
In patients aged 64+: 79.2% of patients achieved a clinically meaningful response (reduced pain and improved knee function) in the Allocetra™ group vs. 47.6% in the placebo group at 12 months (p=0.027)1 Allocetra™ treatment benefit at 12 months was consistent with the response rates observed at 3 and 6 months, demonstrating a durable effect from a single treatment cycle The 12-month data will be presented at the American College of Rheumatology (ACR) Convergence in a poster presentation on November 8, 2026 Nes-Ziona, Israel, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd...
Lyell Immunopharma To Participate in November Investor Events
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in the following investor events: Goldman Sachs' RxChange Series: Framing Lyell's next-generation lymphoma CAR-T data in 4Q Format: Fireside ChatFeatured Speaker: Alexander P...
Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
AUSTIN, Texas, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, President and Chief Executive Officer of Rein Therapeutics, will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference on Monday, November 9, 2026, at 11:00 a.m. ET. A live webcast of the presentation may be accessed via the Investors section of the Rein website at ir.reintx.com...
Syntec Optics (Nasdaq: OPTX) Secures 25% Order Increase for Advanced Space Reconnaissance
ROCHESTER, NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of deep-tech space solutions, has secured a nearly 25% increase in orders for advanced space reconnaissance, building on a major program announced two months ago. Dean Rudy, CFO, stated: "Our open capacity, increased profitability, and bank debt-free balance sheet allow us to scale unhindered...
Gold.com Appoints Nick Bowkett as Vice President of Trading and Business Development
COSTA MESA, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Gold.com, Inc. (NYSE: GOLD), (“Gold.com” or the “Company”), a fully integrated alternative assets platform that offers an extensive range of precious metals, numismatic coins, and collectibles to consumers, collectors, and institutional clients worldwide, today announced the appointment of Nick Bowkett as Vice President of Trading and Business Development, effective November 2, 2026...
Rectitude Holdings Ltd. Announces Acquisition of MR.
Rectitude has signed a Share Purchase Agreement to acquire 100% of Mr. Butler, adding household goods repair and personal service activities to its product portfolio.
Stratum Holdings CEO Issues Shareholder Letter Highlighting Progress in AI Infrastructure Transformation
NVIDIA B300 GPU Leasing Operations Establish Foundation for Recurring Revenue as Company Advances Proposed Real Estate Divestiture, Expected to Reduce Legacy Operating Costs, Strengthen Balance Sheet and Support Long-Term Growth Proposed Ocean Power Technologies Collaboration Expands Potential AI Infrastructure Applications Through Offshore, Renewable-Powered Computing CELEBRATION, FL, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Stratum Holdings Corp. (NASDAQ: SRTM) (“Stratum”) today issued a letter to shareholders from Chief Executive Officer Nicholas H. Adler outlining the Company's progress in executing its strategic transformation, including its NVIDIA B300 GPU leasing business, proposed divestiture of legacy real estate operations and development of new AI infrastructure opportunities...
The Office Gurus Announces Acquisition of Select VoiceCom, Expanding Global Delivery Capabilities in the Philippines
ST. PETERSBURG, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Office Gurus (TOG), the Contact Centers segment of Superior Group of Companies, Inc. (NASDAQ: SGC), today announced the acquisition of Select VoiceCom (SVC), a Philippines-based business process outsourcing (BPO) provider with delivery centers in Cebu City and Davao...
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
ZUG, Switzerland and BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), today announced the appointment of Sivakesava (Siva) Sakhamuri, Ph.D., as Chief Technical Officer, effective immediately.
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
CALABASAS, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced that data from its intranasal NEO100 and oral NEO212 programs will be presented in two posters on Friday, November 13, at the 31st Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), held November 12 to 15, 2026, at the Pennsylvania Convention Center in Philadelphia...
HyOrc Reports 75.43% Combined Hydrogen and Carbon Monoxide in RDF-Derived Syngas, with Just 0.76% Nitrogen
HOUSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCQB: HYOR) announced independent laboratory results from its first commercial module, demonstrating exceptionally low nitrogen dilution in refuse-derived fuel (RDF) syngas. Prewel Laboratories measured 39.88% carbon monoxide, 35.55% hydrogen and 0.76% nitrogen after gasification and gas cleaning, before water-gas shift reaction, membrane separation and stoichiometric conditioning for methanol synthesis...
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026
FLORHAM PARK, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that the company will report financial results for the third quarter ended September 30, 2026, and provide a corporate update on November 10, 2026, at 8:30 a.m...
CytomX Therapeutics to Present at Upcoming November Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor conferences in November.
General Fusion to Host Third Quarter 2026 Results Conference Call
VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- General Fusion Group Ltd. (NASDAQ: GFUZ) (“General Fusion” or the “Company”), a leader in the global race to commercialize fusion energy, today announced it will release its financial results and provide business updates for the third quarter of 2026 after market close on Monday, November 16, 2026, followed by a conference call at 5:00 p.m...
ZIM to Release Third Quarter 2026 Results on Wednesday, November 18, 2026
HAIFA, Israel, Nov. 2, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) announced today that the Company will release its third quarter 2026 financial results on Wednesday, November 18, 2026, before the U.S. financial markets open.
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
WILMETTE, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that two abstracts related to ALXN1840 (tiomolibdate choline, TMC), the Company's investigational therapy for Wilson disease, will be presented at the American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting 2026, taking place Nov. 5–9, 2026, at the Colorado Convention Center in Denver, Colorado...
ReposiTrak Schedules Fiscal 2027 First Quarter Earnings Conference Call and Webcast for November 16, 2026
SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced that the Company plans to release earnings results for its fiscal 2027 first quarter after the market closes on Monday, November 16, 2026. Randall K. Fields, Chairman and CEO, will host a conference call at 4:15 p.m. Eastern that day to discuss the Company's results...
Acadia Realty Trust Reports Third Quarter 2026 Operating Results
RYE, N.Y.--(BUSINESS WIRE)--Acadia Realty Trust (NYSE: AKR) (“Acadia” or the “Company”) today reported operating results for the quarter ended September 30, 2026. All per share amounts are on a fully-diluted basis, where applicable. Acadia owns and operates a high-quality real estate portfolio of street and open-air retail properties in the nation's most dynamic retail corridors (“REIT Portfolio”), along with an investment management platform that targets opportunistic and value-add investments...
Box Sets Date to Announce Third Quarter Fiscal 2027 Financial Results
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Box, Inc. (NYSE:BOX) today announced that it will report financial results for its third quarter fiscal 2027, which ended October 31, 2026, following the close of the market on Tuesday, December 1, 2026. On that day, Box's management will hold a conference call and webcast at 2:00 p.m. PT to discuss Box's financial results and business developments. The conference call can be accessed by registering online https://events.q4inc.com/attendee/126014257 at whi...
Okta to Announce Third Quarter Fiscal Year 2027 Financial Results on December 1, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (NASDAQ: OKTA), the leading independent identity partner, today announced that it will release its financial results for its third quarter fiscal year 2027 ended October 31, 2026 after the U.S. market close on Tuesday, December 1, 2026. Okta will host a live video webcast that day at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss the results. Event: Okta's Third Quarter Fiscal Year 2027 Financial Results Date: Tuesday, December 1, 2026 Time...
Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
China Resources Medical Devices to serve as exclusive distributor for Baird's microwave ablation (MWA) products in 19 markets in the PRC Agreement includes initial purchase order of RMB 6 million ($900,000) NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a global leader in microwave ablation (MWA) technology, today announced that its PRC subsidiary, Nanjing Changcheng Medical Equipment Company Limited, has entered into a distribution agreement with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. (“China Resources Medical Devices”), a subsidiary of China Resources Pharmaceutical Group Limited (Stock Code: 03320.HK)...
DeFi Development Corp. Surpasses 2.6 Million SOL as CHAD's 14% Annualized Dividend Rate Takes Effect
Company adds 5,336 SOL, bringing total treasury holdings to 2,600,948 SOL and SOL equivalents CHAD's new 14.00% annual dividend rate takes effect today, offering investors one of the highest yields in digital credit BOCA RATON, FL, Nov. 02, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company" or "DeFi Dev Corp."), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced that its total holdings of SOL and SOL equivalents increased by 5,336 SOL since its last update, bringing its treasury to approximately 2,600,948 SOL, up from 2,595,612 SOL. The Company continues to accumulate SOL as adoption of the Solana network expands, particularly in tokenized equities and other real-world assets...
AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry
First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs.
Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
FORT MILL, S.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced that its VIVO system has received FDA 510(k) clearance for expanded labeling in its Indications for Use statement.
Alliance Laundry to Present at Baird's 2026 Global Industrial Conference
RIPON, Wis.--(BUSINESS WIRE)--Alliance Laundry Holdings Inc. (NYSE: ALH), the global leader in commercial laundry equipment, will present at the Baird 2026 Global Industrial Conference in Chicago. Mike Schoeb, Chief Executive Officer, and Dean Nolden, Chief Financial Officer, will participate in a fireside chat on Thursday, November 12, 2026, at 7:55 CT. A live webcast of the presentation will be available on the Company's website at: https://ir.alliancelaundry.com/news-events/ir-calendar. A re...
Guerrilla RF Reports Record Third Quarter 2026 Results
GREENSBORO, N.C.--(BUSINESS WIRE)--Guerrilla RF, Inc. (OTCQX: GUER) (“Guerrilla RF” or the “Company”), a leading provider of high-performance RF and microwave semiconductors, today reported record financial results for the third quarter ended September 30, 2026. A recorded webcast of management's commentary reviewing the Q3 2026 financial results and an update on the business will be available on the Company's website today, November 2, 2026 (see details below). “Our record third-quarter result...
Bedrock Environmental Seed & Supply Joins SiteOne Landscape Supply
ROSWELL, Ga.--(BUSINESS WIRE)--SiteOne Landscape Supply, Inc. (NYSE: SITE) announced today that it has completed the acquisition of Bedrock Environmental Seed & Supply, a leading distributor of erosion control, seed, and landscape supplies serving customers throughout 40 states in the U.S. “This acquisition strengthens our position in the erosion control market with a highly respected organization,” said Doug Black, Chairman and CEO of SiteOne. “Bedrock expands our capabilities in attracti...
Motorcar Parts of America to Report Fiscal 2027 Second Quarter Results; Host Conference Call
LOS ANGELES--(BUSINESS WIRE)--Motorcar Parts of America, Inc. (Nasdaq: MPAA) today announced the company will issue its fiscal 2027 second quarter results on Monday, November 9, 2026. Selwyn Joffe, chairman, president and chief executive officer, and David Lee, chief financial officer, will host an investor conference call the same day at 10:00 a.m. Pacific time to discuss the company's financial results and operations. The call will be open to all interested investors either through a live Web...
Masco Corporation to Participate in a Fireside Chat at an Investor Conference
LIVONIA, Mich.--(BUSINESS WIRE)--Masco Corporation (NYSE: MAS) announced today that Jon Nudi, President and Chief Executive Officer, will participate in a fireside chat at Baird's 2026 Global Industrial Conference in Chicago, Illinois on Wednesday, November 11, at 11:50 a.m. ET. The presentation will be audio webcast live under the Investor Relations section of the Company's website at www.masco.com. A replay of the webcast will be available until February 9, 2027. Masco Corporation's press rel...
AI Innovation Takes Center Stage at PowerPlan ELEVATE 2026
NASHVILLE, Tenn., Nov. 02, 2026 (GLOBE NEWSWIRE) -- As energy companies increase capital investment to meet unprecedented demand, finance teams face a dual challenge: recovering that investment while keeping rates affordable for the consumers they serve.
Summit Royalties Promotes Kathy Lai to Chief Financial Officer
TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Summit Royalties Ltd. (TSXV: SUM, OTCQX: SUMMF) ("Summit" or the "Corporation") is pleased to announce the promotion of Kathy Lai to Chief Financial Officer and Corporate Secretary, effective as of November 1, 2026. Ms. Lai succeeds Robert Doyle, who had served as Summit's Chief Financial Officer and Corporate Secretary since its go-public transaction in November 2025...
AAR announces proposed offering of $955 million of senior notes due 2031 and $960 million of senior notes due 2034
WOOD DALE, Ill., Nov. 2, 2026 /PRNewswire/ -- AAR CORP.
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.095 per Share for November 2026
HOUSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a monthly distribution of $0.095 per share for November 2026. This distribution is payable to common stockholders on November 30, 2026 (as outlined in the table below)...
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Clarivate to Bring Trusted Trademark Data into Microsoft Copilot Through IPOne
LONDON, Nov. 2, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced it will bring trusted CompuMark trademark data and insights into Microsoft Copilot through IPOne, enabling intellectual property (IP) professionals to put authoritative trademark intelligence to work directly within AI-powered workflows. As AI changes how IP professionals research, analyze and make decisions, the quality of the data behind those decisions matters more than ever...
SAIC Announces Proposed Offering of $400 Million in Senior Notes
RESTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) a leading mission integrator supporting defense, space, intelligence, and civilian agencies, announced today that it intends to commence an offering of $400 million aggregate principal amount of senior notes due 2034 (the “Notes”), subject to market and certain other conditions (the “Offering”). The Notes will be guaranteed on a senior unsecured basis by each of SAIC's existing and future domestic subsidiaries that guarantee SAIC's obligations under its credit agreement and certain other indebtedness, including its 5.875% Senior Notes due 2033...
HPE to Present Live Audio Webcast of Fiscal 2026 Fourth Quarter Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--HPE (NYSE: HPE) will conduct a live audio webcast of a conference call with analysts to review financial results for the fourth quarter of fiscal 2026, ending October 31, 2026. The call is scheduled for Monday, November 23 at 4:00 p.m. CT (5:00 p.m. ET), and the webcast will be available at www.hpe.com/investor/2026Q4Webcast. A replay of the webcast will be available at the same website shortly after the call and will remain available for approximately one year. For ad...
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing
Filament has completed a new extraction of IBEX011 The Company expects Filament to begin stability testing on the new extract shortly Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and supplies PEX010, its patented, standardized, GMP-manufactured botanical psilocybin drug candidate, to clinical research and compassionate access programs at leading institutions worldwide...
ArcelorMittal announces the publication of its third quarter 2026 sell-side analyst consensus figures
2 November 2026, 13:30 CET ArcelorMittal (‘the Company') today announces the publication of its third quarter 2026 sell-side analyst consensus figures. The consensus figures are based on analysts' estimates recorded on an external web-based tool provided and managed by an independent company, Visible Alpha...
Quantum X Labs Announces Cyber Quantum Encryption Breakthrough in Demonstration with IBM Quantum Processor, Heron r2
In its first run on a real quantum processor, Quantum X Labs' Qatacomb scheme successfully recovered an encrypted image using a 156-qubit machine, while an adversary without the key gained no usable information in the demonstration, illustrating a privacy guarantee designed to hold regardless of an adversary's computing power
Thunder Gold Announces Pierre A.J. Julien, MBA, CIMF as Director
Thunder Bay, Ontario--(Newsfile Corp. - November 2, 2026) - Thunder Gold Corp. (TSXV: TGOL) (FSE: Z25) (OTCQB: TGOLF) ("Thunder Gold" or the "Company") is pleased to announce the addition of Pierre A. J. Julien to the Company's Board of Directors.
Revival Gold Advances Pre-Feasibility Study and Permitting Work at Mercur, Utah's Largest Primary Gold Development Project
Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - Revival Gold Inc. (TSXV: RVG) (OTCQX: RVLGF) ("Revival Gold" or the "Company") is pleased to provide an update on the Mercur Gold Project ("Mercur" or, the "Project"), Utah's largest primary gold development project1. "Over the past 18 months, Revival Gold has completed 24 kilometers of resource delineation drilling at Mercur...
Better Just Got Bigger: Papa Johns Canada Introduces New 16-Inch XL Pizza
EDMONTON, Alberta, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Bigger is officially better at Papa Johns Canada. Beginning today, the brand is introducing its new 16-inch XL Pizza, bringing more of the flavour Canadians love in a size that lives up to its name.
Kaplan Fox Reminds UP Fintech Holding Limited (TIGR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on December 28, 2026
New York, New York--(Newsfile Corp. - November 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against UP Fintech Holding Limited ("UP Fintech" or the "Company") (NASDAQ: TIGR) on behalf of investors that purchased or otherwise acquired UP Fintech securities between April 22, 2024 and June 2, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in UP Fintech and have suffered losses, you may CLICK HERE to contact us...
Cognition Therapeutics to Host Third Quarter 2026 Financial Results and Business Update Call on November 5, 2026
-- Conference Call and Webcast 8:30 a.m. ET November 5 -- PURCHASE, N.Y., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders (the “Company” or “Cognition”), today announced that the Company will host a conference call and webcast on November 5, 2026, at 8:30 a.m. Eastern Time to report its financial results for the third quarter ended September 30, 2026, and provide a business update...
Quantum Cyber Publishes Investor Explanatory Materials on Its Quantum Antenna Technology, Including Technical Summary and Companion Video
Materials Include a Technical Summary of the Photo-Mag Antenna Authored by Wolf Kohn, PhD, Chief Scientist of Project LightShift, and a Companion Explainer Video Prepared for Investor Audiences Materials Include a Technical Summary of the Photo-Mag Antenna Authored by Wolf Kohn, PhD, Chief Scientist of Project LightShift, and a Companion Explainer Video Prepared for Investor Audiences
Curaleaf Acquires Equity Interest in Boone Town Provisions, Expanding New Jersey Footprint to Four Dispensaries
STAMFORD, Conn., Nov. 2, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (the "Company"), a leading international provider of consumer and medical cannabis products, today announced that it has acquired an equity stake and certain operating rights in Boone Town Provisions, a dispensary located at 677 Myrtle Ave...
Crescent Biopharma to Present at November Investor Conferences
WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November:
Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations, including two Late Breaking Oral Abstract presentations and one poster presentation, at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions, held in collaboration with the American Heart Association Scientific Sessions, taking place in Chicago, IL, November 6, 2026...
3D Systems Expands European Dental Presence Through Partnership with BioSummer Dental
ROCK HILL, S.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE: DDD) today announced an expansion of its long-standing strategic distribution partnership with BioSummer Dental, a France-based distributor of advanced digital dentistry solutions.
Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that the U.S. Food and Drug Administration (“FDA”) has notified the Company via email that its investigational new drug application (“IND”) for Developmental and Epileptic Encephalopathies (“DEEs”) and related Protocol BMB-101-105 has been placed on a partial clinical hold following the FDA's review. The proposed trial related to this IND is a randomized, placebo-controlled, double-blind Phase 2 study designed to evaluate the efficacy and safety of ascending doses of BMB-101, up to a maximum tolerated dose, for the treatment of seizures associated with DEEs...
CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position
PARSIPPANY, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today provided a business update in advance of a conference call expected to be held on November 12, 2026 to discuss the Company's complete quarterly financial performance.
Rezolute to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by any form of hyperinsulinism (HI), today announced that management will participate in the following investor conferences: Event: Guggenheim 3rd Annual Healthcare Innovation Conference Date: November 9-11, 2026 Fireside Date/Time: Monday, November 9th at 9:00am ET Event: Jefferies London Healthcare Conference Date: November 16-19, 2026 Fireside Date/Time: Thursday, November 19th at 1:00pm GMT Management will be participating in one-on-one investor meetings throughout the conferences...
Streamex Corp. to Report Third Quarter 2026 Results and Host Business & Corporate Update Call
WINTER PARK, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today announced that it will release its financial results for the third quarter on Thursday, November 12, 2026, and host a corresponding earnings and corporate update presentation that same day at 4:30 p.m...
Avicanna to Report Q3 2026 Results and Host Call on Nov. 12
TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products announces November 12, 2026, as the date for reporting Q3 2026 financial results and that management will host a live webcast at 8:30 a.m. ET that morning to present the results, provide a corporate update...
Max Hospitality Selects Beyond Oil as Frying Standard Across Its Restaurants and Venues
Hartford-based group of chef-driven restaurants and catering serving Connecticut and Massachusetts since 1986, endorses Beyond Oil's frying technology Hartford-based group of chef-driven restaurants and catering serving Connecticut and Massachusetts since 1986, endorses Beyond Oil's frying technology
Dynacor Feeds First Ore to Ecuador Mill
Dynacor updates on its Svetlana plant in Ecuador as it advances towards production restart. Svetlana was +80% complete as at September 30 and on budget.
Foremost Clean Energy Announces Commencement of Inaugural Drill Program at the Turkey Lake Property
VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce that it has commenced its first diamond drill program on the Turkey Lake Uranium Project (“Turkey Lake”) in northern Saskatchewan (Figure 1)...
TG Therapeutics to Host Conference Call on Third Quarter 2026 Financial Results and Business Update
NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, November 9, 2026, at 8:30 AM ET to discuss results for the third quarter 2026 and to provide a business outlook for the remainder of 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnin...
The Beachbody Company, Inc. Announces Third Quarter 2026 Earnings Release Date, Conference Call, and Webcast
EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NASDAQ: BODI) (“BODi” or the “Company”), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, will release its third quarter 2026 results on Tuesday, November 10, 2026, after the U.S. stock market closes. The Company will host a conference call at 5:00 p.m. (Eastern Time) that day to discuss the results. The toll-free dial-in fo...
Immunome to Present at Guggenheim 3rd Annual Healthcare Innovation Conference
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that its management will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026, at 9 a.m. EST. Interested parties can access the live audio webcast of the presentation from the Investor Relations section of the company's website at www.immunome.com. The w...
Verastem Oncology to Participate in Upcoming November Investor Conferences
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to present at the following investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference in Boston: November 9, 4:00-4:25pm ET Wolfe Research Healthcare Conference in New York City: November 10, 4:00-4:30pm ET Jefferies London Healthcare Conference in Lo...
Valvoline Inc. Kicks Off Annual Children's Miracle Network® Fundraising Campaign
LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today kicked off its annual in-store fundraising campaign benefiting Children's Miracle Network. Throughout November, customers at participating Valvoline Instant Oil Change, Great Canadian Oil Change, and Oil Changers locations can donate to support children and families in their local communities. This year marks Valvoline Inc.'s 17th year supporting Children's Mi...
Siva Barnwell Adams Named Corporate Secretary and Chief Governance Officer
HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) has named Siva Barnwell Adams corporate secretary and chief governance officer, effective Jan. 1, 2027.In her new role, Barnwell Adams will counsel the board of directors and Chevron's senior management on corporate governance matters, manage the Corporate Governance Department and serve on the Law Function Executive Committee. She succeeds Mary A. Francis, who will retire from Chevron in May 2027 after 25 years with the company.“Siva bri...